Stock HLS HLS THERAPEUTICS INC.
Add to a list
To use this feature you must be a member
Log inSign up

Press Releases HLS Therapeutics Inc.

Equities

HLS

CA40390B1094

Market Closed - Toronto S.E.
Other stock markets
 15:37:59 08/05/2024 BST 		5-day change 1st Jan Change
4.78 CAD +1.06% Intraday chart for HLS Therapeutics Inc. +2.80% +21.01%
04-08 HLS Therapeutics Inc. Announces Reduce-IT Analysis Results Relating the Effects of VASCEPA CI
03-14 Transcript : HLS Therapeutics Inc., Q4 2023 Earnings Call, Mar 14, 2024

Press Releases

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
HLS Therapeutics to Host Q1 Fiscal 2024 Financial Results Conference Call
AQ
HLS Therapeutics to Present at the 2024 Bloom Burton & Co. Healthcare Investor Conference
AQ
New REDUCE-IT® Analyses Show VASCEPA® (Icosapent Ethyl) Benefit in High-Risk Cardiovascular Disease Patient Subgroups
AQ
HLS Therapeutics Announces Fiscal 2023 Financial Results
AQ
HLS Therapeutics to Host Q4 and Fiscal 2023 Financial Results Conference Call
AQ
HLS Announces that Vascepa is now reimbursed by British Columbia's Provincial Drug Plan
AQ
HLS Announces that Vascepa® is now reimbursed by British Columbia's Provincial Drug Plan
AQ
HLS Therapeutics Announces CFO Departure
AQ
HLS - New REDUCE-IT Analyses Show Vascepa Associated with 29 Percent Relative Risk Reduction Compared with Placebo in Prespecified Subgroup of Patients with Metabolic Syndrome, but Without Diabetes at Baseline
AQ
New REDUCE-IT® Analyses Show Vascepa® (Icosapent Ethyl) Associated with 29 Percent Relative Risk Reduction Compared with Placebo in Prespecified Subgroup of Patients with Metabolic Syndrome, but Without Diabetes at Baseline
AQ
HLS Therapeutics Announces Q3 Fiscal 2023 Financial Results and Renewal of Normal Course Issuer Bid
AQ
HLS Therapeutics to Host Q3 Fiscal 2023 Financial Results Conference Call
AQ
HLS Therapeutics to Present at H.C. Wainwright's 25th Annual Global Investment Conference
AQ
HLS Therapeutics Announces Updates to its Credit Agreement
AQ
HLS Therapeutics Announces Q2 Fiscal 2023 Financial Results
AQ
HLS Therapeutics to Host Q2 Fiscal 2023 Financial Results Conference Call
AQ
HLS Therapeutics Announces Updates to its Board of Directors
AQ
HLS Therapeutics Reports Annual Meeting Results
AQ
HLS Therapeutics Announces Agreement with Polar Asset Management Partners and Retirement of Two Directors from the Board of Directors
AQ
HLS Therapeutics Announces Q1 Fiscal 2023 Financial Results
AQ
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. HLS Stock
  4. News HLS Therapeutics Inc.
  5. Press Releases